Global Wearable Injectors Market Type (On Body, Off Body) By Technology (Mechanical, Electronics) By Mechanism (Spring Based, Motor Driven, Rotary Pump, Pressurized Gas, Expanding Battery, Others) By Application (Diabetes, Cardiovascular disorders, Oncology, Infectious Disease, Autoimmune Disease, Others) By End User (Hospitals and Clinics, Home Care Centers, Ambulatory Centers, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
The medication delivery sector is evolving quickly, and firms' capacity to create and introduce new products is frequently outpaced by innovation. Patients' requests for greater flexibility in their treatment plans have always been the driving force behind these modifications. The necessity for a patient to arrange an office visit in order to discuss or modify their medication regimen is long gone thanks to the development of autonomous drug-delivery systems, which have given patients more control over their medical care. However, there is still opportunity for improvement given the work required and the risk of inaccuracy involved with conventional medication administration techniques. Attached to the body, wearable injectable systems automatically provide predetermined amounts to patients at the best moments, which is driving the global wearable injectors market. Wearable injectable devices are the logical next step in the evolution of chronic disease management in a culture where everything is expected to happen instantly. The idea of patient-centricity and a growing emphasis on human factors in drug-delivery design have sparked the creation of these devices.
Manufacturers are aware that there was a market gap when discussing the use case for these items. Prefilled syringes and autoinjectors, on one hand, are not designed for delivery intervals longer than 20 seconds, while insulin pumps, on the other hand, are too costly and complicated for periodic fixed volume medication delivery. Both of these gaps are intended to be filled by wearable injectable systems, which allow for discrete, comfortable administration of precisely dosed drugs over predetermined or flexible time periods. Additionally, wearable technology offers more potential for connectivity between digital health platforms and the devices themselves. These devices' unique level of digital control and oversight may be provided by the ability to include additional electronics into their design. The patient can modify the delivery volume or flow rate through connected applications in accordance with their preferences or recommendations from their doctor. These devices can even communicate with other external devices, such as glucose metres, in the context of diabetes management, actively monitoring blood glucose levels and modifying the insulin delivery profile. These closed loop systems mark a significant advancement in using artificial intelligence to benefit patients. Greater treatment transparency can frequently enhance patient outcomes by enabling doctors to identify possible problems before they arise. According to current trends, the wearable injectors market will keep growing globally, necessitating an increase in testing capacities for both R&D and quality labs. Equipment makers will need to further specialise their test systems in order to meet these demands, cooperating with international device manufacturers to stay on top of the game.
Self-administration devices are being utilised more frequently since most people prefer to take care of themselves in the comfort of their own home or personal space. Most people chose home treatment when the COVID-19 epidemic started because they didn't want to get the sickness. Therefore, COVID-19 encouraged those who required continuous drug delivery or treatment to adopt self-administration devices. The market for wearable injectors is therefore anticipated to expand as a result of people's increased reliance on self-administration tools.
In terms of revenue, global wearable injectors market was valued at US$ 6.6 Bn in 2021 and is growing at a CAGR of 15.3% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Technology Outlook
Based on the technology segment, the global wearable injectors market is segmented into mechanical and electronic. Due to various challenges faced by the mechanical wearable injectors, the demand for electronic injectors is rising considerably. Various electronic wearable injectors which are customizable to support different treatment regimens (pulsatile, continuous, episodic, or single-bolus delivery) are being launched. Moreover these injectors are equipped with smart capabilities to support remote and secure communication via bluetooth and it includes options for a wearable wireless monitor or app integration. Thus, with such advancements the wearable injectors market is upsurging globally.
Global Wearable Injectors Market Revenue & Forecast, (US$ Million), 2015 – 2030
Region Outlook
Based on the region, North America had the highest share in the wearable injectors market in the year 2021. The wearable injectors market is growing as a result of the growth in demand for more sophisticated treatment options for chronic diseases like diabetes. Additionally, there has been an increase in the focus of major players on the introduction of new products into the market. For instance, West Pharmaceutical recently announced the addition of several new wearable injectors to its SmartDose drug delivery platform, allowing patients to inject 10 mL volume in convenient, wearable formats. Additionally, the market or fwearable injectors in the United States and Canada is anticipated to be significantly impacted by advances in medical technology for the treatment of diseases.
Competitive Landscape
The report provides both, qualitative and quantitative research of global wearable injectors market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global wearable injectors market are mentioned below:
- Amgen
- BD
- Bühler Motor GmbH
- EOFLOW CO., LTD.
- Gerresheimer AG
- Insulet Corporation
- Neuma LLC
- Sonceboz
- United Therapeutics
- West Pharmaceutical Services
- Ypsomed AG
- Other Industry Participants
Global Wearable Injectors Market
By Type
- On body
- Off body
By Technology
- Mechanical
- Electronic
By Mechanism
- Spring Based
- Motor Driven
- Rotary Pump
- Pressurized Gas
- Expanding Battery
- Others
By Application
- Diabetes
- Cardiovascular Disorders
- Oncology
- Infectious Disease
- Autoimmune Disease
- Others
By End User
- Hospitals and Clinics
- Home Care Centers
- Ambulatory Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Wearable Injectors Market
6.
Market
Synopsis:Â Wearable Injectors Market
7.
Wearable
Injectors Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Wearable Injectors Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Wearable Injectors Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Wearable Injectors
Market
8.
Global
Wearable Injectors Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Wearable Injectors Market Revenue (US$
Mn)
8.2. Global Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Type
8.2.1. On body
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 – 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. Off body
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market
Forecast, 2022 – 2030
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global
Wearable Injectors Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Technology
9.2.1. Mechanical
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 – 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Electronic
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 – 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Technology
10. Global Wearable Injectors Market Analysis
and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Mechanism
10.2.1. Spring based
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 – 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Motor driven
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 – 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Rotary Pump
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 – 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.2.4. Pressurized gas
10.2.4.1.
Definition
10.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.4.3.
Market
Forecast, 2022 – 2030
10.2.4.4.
Compound
Annual Growth Rate (CAGR)
10.2.4.5.
Regional
Bifurcation
10.2.4.5.1.
North
America
10.2.4.5.1.1. Market Estimation, 2015 - 2021
10.2.4.5.1.2. Market Forecast, 2022 – 2030
10.2.4.5.2.
Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2021
10.2.4.5.2.2. Market Forecast, 2022 – 2030
10.2.4.5.3.
Asia
Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2021
10.2.4.5.3.2. Market Forecast, 2022 – 2030
10.2.4.5.4.
Middle
East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2021
10.2.4.5.4.2. Market Forecast, 2022 – 2030
10.2.4.5.5.
Latin
America
10.2.4.5.5.1. Market Estimation, 2015 - 2021
10.2.4.5.5.2. Market Forecast, 2022 – 2030
10.2.5. Expanding battery
10.2.5.1.
Definition
10.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.5.3.
Market
Forecast, 2022 – 2030
10.2.5.4.
Compound
Annual Growth Rate (CAGR)
10.2.5.5.
Regional
Bifurcation
10.2.5.5.1.
North
America
10.2.5.5.1.1. Market Estimation, 2015 - 2021
10.2.5.5.1.2. Market Forecast, 2022 – 2030
10.2.5.5.2.
Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2021
10.2.5.5.2.2. Market Forecast, 2022 – 2030
10.2.5.5.3.
Asia
Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2021
10.2.5.5.3.2. Market Forecast, 2022 – 2030
10.2.5.5.4.
Middle
East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2021
10.2.5.5.4.2. Market Forecast, 2022 – 2030
10.2.5.5.5.
Latin
America
10.2.5.5.5.1. Market Estimation, 2015 - 2021
10.2.5.5.5.2. Market Forecast, 2022 – 2030
10.2.6. Others
10.2.6.1.
Definition
10.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.6.3.
Market
Forecast, 2022 – 2030
10.2.6.4.
Compound
Annual Growth Rate (CAGR)
10.2.6.5.
Regional
Bifurcation
10.2.6.5.1.
North
America
10.2.6.5.1.1. Market Estimation, 2015 - 2021
10.2.6.5.1.2. Market Forecast, 2022 – 2030
10.2.6.5.2.
Europe
10.2.6.5.2.1. Market Estimation, 2015 - 2021
10.2.6.5.2.2. Market Forecast, 2022 – 2030
10.2.6.5.3.
Asia
Pacific
10.2.6.5.3.1. Market Estimation, 2015 - 2021
10.2.6.5.3.2. Market Forecast, 2022 – 2030
10.2.6.5.4.
Middle
East and Africa
10.2.6.5.4.1. Market Estimation, 2015 - 2021
10.2.6.5.4.2. Market Forecast, 2022 – 2030
10.2.6.5.5.
Latin
America
10.2.6.5.5.1. Market Estimation, 2015 - 2021
10.2.6.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Mechanism
11. Global Wearable Injectors Market Analysis
and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Application
11.2.1. Diabetes
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 – 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Cardiovascular disorders
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 – 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Oncology
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 – 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.2.4. Infectious Disease
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market
Forecast, 2022 – 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 – 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 – 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 – 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 – 2030
11.2.5. Autoimmune Disease
11.2.5.1.
Definition
11.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.5.3.
Market
Forecast, 2022 – 2030
11.2.5.4.
Compound
Annual Growth Rate (CAGR)
11.2.5.5.
Regional
Bifurcation
11.2.5.5.1.
North
America
11.2.5.5.1.1. Market Estimation, 2015 - 2021
11.2.5.5.1.2. Market Forecast, 2022 – 2030
11.2.5.5.2.
Europe
11.2.5.5.2.1. Market Estimation, 2015 - 2021
11.2.5.5.2.2. Market Forecast, 2022 – 2030
11.2.5.5.3.
Asia
Pacific
11.2.5.5.3.1. Market Estimation, 2015 - 2021
11.2.5.5.3.2. Market Forecast, 2022 – 2030
11.2.5.5.4.
Middle
East and Africa
11.2.5.5.4.1. Market Estimation, 2015 - 2021
11.2.5.5.4.2. Market Forecast, 2022 – 2030
11.2.5.5.5.
Latin
America
11.2.5.5.5.1. Market Estimation, 2015 - 2021
11.2.5.5.5.2. Market Forecast, 2022 – 2030
11.2.6. Others
11.2.6.1.
Definition
11.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.6.3.
Market
Forecast, 2022 – 2030
11.2.6.4.
Compound
Annual Growth Rate (CAGR)
11.2.6.5.
Regional
Bifurcation
11.2.6.5.1.
North
America
11.2.6.5.1.1. Market Estimation, 2015 - 2021
11.2.6.5.1.2. Market Forecast, 2022 – 2030
11.2.6.5.2.
Europe
11.2.6.5.2.1. Market Estimation, 2015 - 2021
11.2.6.5.2.2. Market Forecast, 2022 – 2030
11.2.6.5.3.
Asia
Pacific
11.2.6.5.3.1. Market Estimation, 2015 - 2021
11.2.6.5.3.2. Market Forecast, 2022 – 2030
11.2.6.5.4.
Middle
East and Africa
11.2.6.5.4.1. Market Estimation, 2015 - 2021
11.2.6.5.4.2. Market Forecast, 2022 – 2030
11.2.6.5.5.
Latin
America
11.2.6.5.5.1. Market Estimation, 2015 - 2021
11.2.6.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By Application
12. Global Wearable Injectors Market Analysis
and Forecasts, 2022 – 2030
12.1. Overview
12.2. Global Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By End User
12.2.1. Hospitals and clinics
12.2.1.1.
Definition
12.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.1.3.
Market
Forecast, 2022 – 2030
12.2.1.4.
Compound
Annual Growth Rate (CAGR)
12.2.1.5.
Regional
Bifurcation
12.2.1.5.1.
North
America
12.2.1.5.1.1. Market Estimation, 2015 - 2021
12.2.1.5.1.2. Market Forecast, 2022 – 2030
12.2.1.5.2.
Europe
12.2.1.5.2.1. Market Estimation, 2015 - 2021
12.2.1.5.2.2. Market Forecast, 2022 – 2030
12.2.1.5.3.
Asia
Pacific
12.2.1.5.3.1. Market Estimation, 2015 - 2021
12.2.1.5.3.2. Market Forecast, 2022 – 2030
12.2.1.5.4.
Middle
East and Africa
12.2.1.5.4.1. Market Estimation, 2015 - 2021
12.2.1.5.4.2. Market Forecast, 2022 – 2030
12.2.1.5.5.
Latin
America
12.2.1.5.5.1. Market Estimation, 2015 - 2021
12.2.1.5.5.2. Market Forecast, 2022 – 2030
12.2.2. Home care centers
12.2.2.1.
Definition
12.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.2.3.
Market
Forecast, 2022 – 2030
12.2.2.4.
Compound
Annual Growth Rate (CAGR)
12.2.2.5.
Regional
Bifurcation
12.2.2.5.1.
North
America
12.2.2.5.1.1. Market Estimation, 2015 - 2021
12.2.2.5.1.2. Market Forecast, 2022 – 2030
12.2.2.5.2.
Europe
12.2.2.5.2.1. Market Estimation, 2015 - 2021
12.2.2.5.2.2. Market Forecast, 2022 – 2030
12.2.2.5.3.
Asia
Pacific
12.2.2.5.3.1. Market Estimation, 2015 - 2021
12.2.2.5.3.2. Market Forecast, 2022 – 2030
12.2.2.5.4.
Middle
East and Africa
12.2.2.5.4.1. Market Estimation, 2015 - 2021
12.2.2.5.4.2. Market Forecast, 2022 – 2030
12.2.2.5.5.
Latin
America
12.2.2.5.5.1. Market Estimation, 2015 - 2021
12.2.2.5.5.2. Market Forecast, 2022 – 2030
12.2.3. Ambulatory Centers
12.2.3.1.
Definition
12.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.3.3.
Market
Forecast, 2022 – 2030
12.2.3.4.
Compound
Annual Growth Rate (CAGR)
12.2.3.5.
Regional
Bifurcation
12.2.3.5.1.
North
America
12.2.3.5.1.1. Market Estimation, 2015 - 2021
12.2.3.5.1.2. Market Forecast, 2022 – 2030
12.2.3.5.2.
Europe
12.2.3.5.2.1. Market Estimation, 2015 - 2021
12.2.3.5.2.2. Market Forecast, 2022 – 2030
12.2.3.5.3.
Asia
Pacific
12.2.3.5.3.1. Market Estimation, 2015 - 2021
12.2.3.5.3.2. Market Forecast, 2022 – 2030
12.2.3.5.4.
Middle
East and Africa
12.2.3.5.4.1. Market Estimation, 2015 - 2021
12.2.3.5.4.2. Market Forecast, 2022 – 2030
12.2.3.5.5.
Latin
America
12.2.3.5.5.1. Market Estimation, 2015 - 2021
12.2.3.5.5.2. Market Forecast, 2022 – 2030
12.2.4. Others
12.2.4.1.
Definition
12.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
12.2.4.3.
Market
Forecast, 2022 – 2030
12.2.4.4.
Compound
Annual Growth Rate (CAGR)
12.2.4.5.
Regional
Bifurcation
12.2.4.5.1.
North
America
12.2.4.5.1.1. Market Estimation, 2015 - 2021
12.2.4.5.1.2. Market Forecast, 2022 – 2030
12.2.4.5.2.
Europe
12.2.4.5.2.1. Market Estimation, 2015 - 2021
12.2.4.5.2.2. Market Forecast, 2022 – 2030
12.2.4.5.3.
Asia
Pacific
12.2.4.5.3.1. Market Estimation, 2015 - 2021
12.2.4.5.3.2. Market Forecast, 2022 – 2030
12.2.4.5.4.
Middle
East and Africa
12.2.4.5.4.1. Market Estimation, 2015 - 2021
12.2.4.5.4.2. Market Forecast, 2022 – 2030
12.2.4.5.5.
Latin
America
12.2.4.5.5.1. Market Estimation, 2015 - 2021
12.2.4.5.5.2. Market Forecast, 2022 – 2030
12.3. Key Segment for Channeling Investments
12.3.1. By End User
13. North America Wearable Injectors Market
Analysis and Forecasts, 2022 – 2030
13.1. Overview
13.1.1. North America Wearable Injectors Market
Revenue (US$ Mn)
13.2. North America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Type
13.2.1. On body
13.2.2. Off body
13.3. North America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Technology
13.3.1. Mechanical
13.3.2. Electronic
13.4. North America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Mechanism
13.4.1. Spring based
13.4.2. Motor driven
13.4.3. Rotary Pump
13.4.4. Pressurized gas
13.4.5. Expanding battery
13.4.6. Others
13.5. North America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Application
13.5.1. Diabetes
13.5.2. Cardiovascular disorders
13.5.3. Oncology
13.5.4. Infectious Disease
13.5.5. Autoimmune Disease
13.5.6. Others
13.6. North America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By End User
13.6.1. Hospitals and clinics
13.6.2. Home care centers
13.6.3. Ambulatory Centers
13.6.4. Others
13.7. North America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Country
13.7.1. U.S
13.7.1.1.
U.S
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
13.7.1.1.1.
On body
13.7.1.1.2.
Off body
13.7.1.2.
U.S
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.1.2.1.
Mechanical
13.7.1.2.2.
Electronic
13.7.1.3.
U.S
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
13.7.1.3.1.
Spring
based
13.7.1.3.2.
Motor
driven
13.7.1.3.3.
Rotary
Pump
13.7.1.3.4.
Pressurized
gas
13.7.1.3.5.
Expanding
battery
13.7.1.3.6.
Others
13.7.1.4.
U.S
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
13.7.1.4.1.
Diabetes
13.7.1.4.2.
Cardiovascular
disorders
13.7.1.4.3.
Oncology
13.7.1.4.4.
Infectious
Disease
13.7.1.4.5.
Autoimmune
Disease
13.7.1.4.6.
Others
13.7.1.5.
U.S
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
13.7.1.5.1.
Hospitals
and clinics
13.7.1.5.2.
Home
care centers
13.7.1.5.3.
Ambulatory
Centers
13.7.1.5.4.
Others
13.7.2. Canada
13.7.2.1.
Canada
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
13.7.2.1.1.
On body
13.7.2.1.2.
Off body
13.7.2.2.
Canada
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.2.2.1.
Mechanical
13.7.2.2.2.
Electronic
13.7.2.3.
Canada
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
13.7.2.3.1.
Spring
based
13.7.2.3.2.
Motor
driven
13.7.2.3.3.
Rotary
Pump
13.7.2.3.4.
Pressurized
gas
13.7.2.3.5.
Expanding
battery
13.7.2.3.6.
Others
13.7.2.4.
Canada
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
13.7.2.4.1.
Diabetes
13.7.2.4.2.
Cardiovascular
disorders
13.7.2.4.3.
Oncology
13.7.2.4.4.
Infectious
Disease
13.7.2.4.5.
Autoimmune
Disease
13.7.2.4.6.
Others
13.7.2.5.
Canada
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
13.7.2.5.1.
Hospitals
and clinics
13.7.2.5.2.
Home
care centers
13.7.2.5.3.
Ambulatory
Centers
13.7.2.5.4.
Others
13.7.3. Mexico
13.7.3.1.
Mexico
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
13.7.3.1.1.
On body
13.7.3.1.2.
Off body
13.7.3.2.
Mexico
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
13.7.3.2.1.
Mechanical
13.7.3.2.2.
Electronic
13.7.3.3.
Mexico
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
13.7.3.3.1.
Spring
based
13.7.3.3.2.
Motor
driven
13.7.3.3.3.
Rotary
Pump
13.7.3.3.4.
Pressurized
gas
13.7.3.3.5.
Expanding
battery
13.7.3.3.6.
Others
13.7.3.4.
Mexico
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
13.7.3.4.1.
Diabetes
13.7.3.4.2.
Cardiovascular
disorders
13.7.3.4.3.
Oncology
13.7.3.4.4.
Infectious
Disease
13.7.3.4.5.
Autoimmune
Disease
13.7.3.4.6.
Others
13.7.3.5.
Mexico
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
13.7.3.5.1.
Hospitals
and clinics
13.7.3.5.2.
Home
care centers
13.7.3.5.3.
Ambulatory
Centers
13.7.3.5.4.
Others
13.7.4. Rest of North America
13.7.4.1.
Rest of
North America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
13.7.4.1.1.
On body
13.7.4.1.2.
Off body
13.7.4.2.
Rest of
North America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Technology
13.7.4.2.1.
Mechanical
13.7.4.2.2.
Electronic
13.7.4.3.
Rest of
North America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Mechanism
13.7.4.3.1.
Spring
based
13.7.4.3.2.
Motor
driven
13.7.4.3.3.
Rotary
Pump
13.7.4.3.4.
Pressurized
gas
13.7.4.3.5.
Expanding
battery
13.7.4.3.6.
Others
13.7.4.4.
Rest of
North America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Application
13.7.4.4.1.
Diabetes
13.7.4.4.2.
Cardiovascular
disorders
13.7.4.4.3.
Oncology
13.7.4.4.4.
Infectious
Disease
13.7.4.4.5.
Autoimmune
Disease
13.7.4.4.6.
Others
13.7.4.5.
Rest of
North America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End
User
13.7.4.5.1.
Hospitals
and clinics
13.7.4.5.2.
Home
care centers
13.7.4.5.3.
Ambulatory
Centers
13.7.4.5.4.
Others
13.8. Key Segment for Channeling Investments
13.8.1. By Country
13.8.2. By Type
13.8.3. By Technology
13.8.4. By Mechanism
13.8.5. By Application
13.8.6. By End User
14. Europe Wearable Injectors Market Analysis
and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Europe Wearable Injectors Market Revenue (US$
Mn)
14.2. Europe Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Type
14.2.1. On body
14.2.2. Off body
14.3. Europe Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Technology
14.3.1. Mechanical
14.3.2. Electronic
14.4. Europe Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Mechanism
14.4.1. Spring based
14.4.2. Motor driven
14.4.3. Rotary Pump
14.4.4. Pressurized gas
14.4.5. Expanding battery
14.4.6. Others
14.5. Europe Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Application
14.5.1. Diabetes
14.5.2. Cardiovascular disorders
14.5.3. Oncology
14.5.4. Infectious Disease
14.5.5. Autoimmune Disease
14.5.6. Others
14.6. Europe Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By End User
14.6.1. Hospitals and clinics
14.6.2. Home care centers
14.6.3. Ambulatory Centers
14.6.4. Others
14.7. Europe Wearable Injectors Market Revenue (US$
Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1.
France
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.1.1.1.
On body
14.7.1.1.2.
Off body
14.7.1.2.
France
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.1.2.1.
Mechanical
14.7.1.2.2.
Electronic
14.7.1.3.
France
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
14.7.1.3.1.
Spring
based
14.7.1.3.2.
Motor
driven
14.7.1.3.3.
Rotary
Pump
14.7.1.3.4.
Pressurized
gas
14.7.1.3.5.
Expanding
battery
14.7.1.3.6.
Others
14.7.1.4.
France
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
14.7.1.4.1.
Diabetes
14.7.1.4.2.
Cardiovascular
disorders
14.7.1.4.3.
Oncology
14.7.1.4.4.
Infectious
Disease
14.7.1.4.5.
Autoimmune
Disease
14.7.1.4.6.
Others
14.7.1.5.
France
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.1.5.1.
Hospitals
and clinics
14.7.1.5.2.
Home
care centers
14.7.1.5.3.
Ambulatory
Centers
14.7.1.5.4.
Others
14.7.2. The UK
14.7.2.1.
The UK
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.2.1.1.
On body
14.7.2.1.2.
Off body
14.7.2.2.
The UK
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.2.2.1.
Mechanical
14.7.2.2.2.
Electronic
14.7.2.3.
The UK
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
14.7.2.3.1.
Spring
based
14.7.2.3.2.
Motor
driven
14.7.2.3.3.
Rotary
Pump
14.7.2.3.4.
Pressurized
gas
14.7.2.3.5.
Expanding
battery
14.7.2.3.6.
Others
14.7.2.4.
The UK
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
14.7.2.4.1.
Diabetes
14.7.2.4.2.
Cardiovascular
disorders
14.7.2.4.3.
Oncology
14.7.2.4.4.
Infectious
Disease
14.7.2.4.5.
Autoimmune
Disease
14.7.2.4.6.
Others
14.7.2.5.
The UK
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.2.5.1.
Hospitals
and clinics
14.7.2.5.2.
Home
care centers
14.7.2.5.3.
Ambulatory
Centers
14.7.2.5.4.
Others
14.7.3. Spain
14.7.3.1.
Spain
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.3.1.1.
On body
14.7.3.1.2.
Off body
14.7.3.2.
Spain
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.3.2.1.
Mechanical
14.7.3.2.2.
Electronic
14.7.3.3.
Spain
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
14.7.3.3.1.
Spring
based
14.7.3.3.2.
Motor
driven
14.7.3.3.3.
Rotary
Pump
14.7.3.3.4.
Pressurized
gas
14.7.3.3.5.
Expanding
battery
14.7.3.3.6.
Others
14.7.3.4.
Spain
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
14.7.3.4.1.
Diabetes
14.7.3.4.2.
Cardiovascular
disorders
14.7.3.4.3.
Oncology
14.7.3.4.4.
Infectious
Disease
14.7.3.4.5.
Autoimmune
Disease
14.7.3.4.6.
Others
14.7.3.5.
Spain
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.3.5.1.
Hospitals
and clinics
14.7.3.5.2.
Home
care centers
14.7.3.5.3.
Ambulatory
Centers
14.7.3.5.4.
Others
14.7.4. Germany
14.7.4.1.
Germany
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.4.1.1.
On body
14.7.4.1.2.
Off body
14.7.4.2.
Germany
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.4.2.1.
Mechanical
14.7.4.2.2.
Electronic
14.7.4.3.
Germany
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
14.7.4.3.1.
Spring
based
14.7.4.3.2.
Motor
driven
14.7.4.3.3.
Rotary
Pump
14.7.4.3.4.
Pressurized
gas
14.7.4.3.5.
Expanding
battery
14.7.4.3.6.
Others
14.7.4.4.
Germany
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
14.7.4.4.1.
Diabetes
14.7.4.4.2.
Cardiovascular
disorders
14.7.4.4.3.
Oncology
14.7.4.4.4.
Infectious
Disease
14.7.4.4.5.
Autoimmune
Disease
14.7.4.4.6.
Others
14.7.4.5.
Germany
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.4.5.1.
Hospitals
and clinics
14.7.4.5.2.
Home
care centers
14.7.4.5.3.
Ambulatory
Centers
14.7.4.5.4.
Others
14.7.5. Italy
14.7.5.1.
Italy
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.5.1.1.
On body
14.7.5.1.2.
Off body
14.7.5.2.
Italy
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.5.2.1.
Mechanical
14.7.5.2.2.
Electronic
14.7.5.3.
Italy
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
14.7.5.3.1.
Spring
based
14.7.5.3.2.
Motor
driven
14.7.5.3.3.
Rotary
Pump
14.7.5.3.4.
Pressurized
gas
14.7.5.3.5.
Expanding
battery
14.7.5.3.6.
Others
14.7.5.4.
Italy
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
14.7.5.4.1.
Diabetes
14.7.5.4.2.
Cardiovascular
disorders
14.7.5.4.3.
Oncology
14.7.5.4.4.
Infectious
Disease
14.7.5.4.5.
Autoimmune
Disease
14.7.5.4.6.
Others
14.7.5.5.
Italy
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.5.5.1.
Hospitals
and clinics
14.7.5.5.2.
Home
care centers
14.7.5.5.3.
Ambulatory
Centers
14.7.5.5.4.
Others
14.7.6. Nordic Countries
14.7.6.1.
Nordic
Countries Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.6.1.1.
On body
14.7.6.1.2.
Off body
14.7.6.2.
Nordic
Countries Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Technology
14.7.6.2.1.
Mechanical
14.7.6.2.2.
Electronic
14.7.6.3.
Nordic
Countries Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Mechanism
14.7.6.3.1.
Spring
based
14.7.6.3.2.
Motor
driven
14.7.6.3.3.
Rotary
Pump
14.7.6.3.4.
Pressurized
gas
14.7.6.3.5.
Expanding
battery
14.7.6.3.6.
Others
14.7.6.4.
Nordic
Countries Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Application
14.7.6.4.1.
Diabetes
14.7.6.4.2.
Cardiovascular
disorders
14.7.6.4.3.
Oncology
14.7.6.4.4.
Infectious
Disease
14.7.6.4.5.
Autoimmune
Disease
14.7.6.4.6.
Others
14.7.6.5.
Nordic
Countries Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.6.5.1.
Hospitals
and clinics
14.7.6.5.2.
Home
care centers
14.7.6.5.3.
Ambulatory
Centers
14.7.6.5.4.
Others
14.7.6.6.
Nordic
Countries Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Country
14.7.6.6.1.
Denmark
14.7.6.6.2.
Finland
14.7.6.6.3.
Iceland
14.7.6.6.4.
Sweden
14.7.6.6.5.
Norway
14.7.7. Benelux Union
14.7.7.1.
Benelux
Union Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.7.1.1.
On body
14.7.7.1.2.
Off body
14.7.7.2.
Benelux
Union Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.7.2.1.
Mechanical
14.7.7.2.2.
Electronic
14.7.7.3.
Benelux
Union Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
14.7.7.3.1.
Spring
based
14.7.7.3.2.
Motor
driven
14.7.7.3.3.
Rotary
Pump
14.7.7.3.4.
Pressurized
gas
14.7.7.3.5.
Expanding
battery
14.7.7.3.6.
Others
14.7.7.4.
Benelux
Union Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
14.7.7.4.1.
Diabetes
14.7.7.4.2.
Cardiovascular
disorders
14.7.7.4.3.
Oncology
14.7.7.4.4.
Infectious
Disease
14.7.7.4.5.
Autoimmune
Disease
14.7.7.4.6.
Others
14.7.7.5.
Benelux
Union Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.7.5.1.
Hospitals
and clinics
14.7.7.5.2.
Home
care centers
14.7.7.5.3.
Ambulatory
Centers
14.7.7.5.4.
Others
14.7.7.6.
Benelux
Union Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Country
14.7.7.6.1.
Belgium
14.7.7.6.2.
The
Netherlands
14.7.7.6.3.
Luxembourg
14.7.8. Rest of Europe
14.7.8.1.
Rest of
Europe Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
14.7.8.1.1.
On body
14.7.8.1.2.
Off body
14.7.8.2.
Rest of
Europe Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
14.7.8.2.1.
Mechanical
14.7.8.2.2.
Electronic
14.7.8.3.
Rest of
Europe Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
14.7.8.3.1.
Spring
based
14.7.8.3.2.
Motor
driven
14.7.8.3.3.
Rotary
Pump
14.7.8.3.4.
Pressurized
gas
14.7.8.3.5.
Expanding
battery
14.7.8.3.6.
Others
14.7.8.4.
Rest of
Europe Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
14.7.8.4.1.
Diabetes
14.7.8.4.2.
Cardiovascular
disorders
14.7.8.4.3.
Oncology
14.7.8.4.4.
Infectious
Disease
14.7.8.4.5.
Autoimmune
Disease
14.7.8.4.6.
Others
14.7.8.5.
Rest of
Europe Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
14.7.8.5.1.
Hospitals
and clinics
14.7.8.5.2.
Home
care centers
14.7.8.5.3.
Ambulatory
Centers
14.7.8.5.4.
Others
14.8. Key Segment for Channeling Investments
14.8.1. By Country
14.8.2. By Type
14.8.3. By Technology
14.8.4. By Mechanism
14.8.5. By Application
14.8.6. By End User
15. Asia Pacific Wearable Injectors Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Asia Pacific Wearable Injectors Market
Revenue (US$ Mn)
15.2. Asia Pacific Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Type
15.2.1. On body
15.2.2. Off body
15.3. Asia Pacific Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Technology
15.3.1. Mechanical
15.3.2. Electronic
15.4. Asia Pacific Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Mechanism
15.4.1. Spring based
15.4.2. Motor driven
15.4.3. Rotary Pump
15.4.4. Pressurized gas
15.4.5. Expanding battery
15.4.6. Others
15.5. Asia Pacific Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Application
15.5.1. Diabetes
15.5.2. Cardiovascular disorders
15.5.3. Oncology
15.5.4. Infectious Disease
15.5.5. Autoimmune Disease
15.5.6. Others
15.6. Asia Pacific Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By End User
15.6.1. Hospitals and clinics
15.6.2. Home care centers
15.6.3. Ambulatory Centers
15.6.4. Others
15.7. Asia Pacific Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Country
15.7.1. China
15.7.1.1.
China
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.1.1.1.
On body
15.7.1.1.2.
Off body
15.7.1.2.
China
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.1.2.1.
Mechanical
15.7.1.2.2.
Electronic
15.7.1.3.
China
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
15.7.1.3.1.
Spring
based
15.7.1.3.2.
Motor
driven
15.7.1.3.3.
Rotary
Pump
15.7.1.3.4.
Pressurized
gas
15.7.1.3.5.
Expanding
battery
15.7.1.3.6.
Others
15.7.1.4.
China
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
15.7.1.4.1.
Diabetes
15.7.1.4.2.
Cardiovascular
disorders
15.7.1.4.3.
Oncology
15.7.1.4.4.
Infectious
Disease
15.7.1.4.5.
Autoimmune
Disease
15.7.1.4.6.
Others
15.7.1.5.
China
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
15.7.1.5.1.
Hospitals
and clinics
15.7.1.5.2.
Home
care centers
15.7.1.5.3.
Ambulatory
Centers
15.7.1.5.4.
Others
15.7.2. Japan
15.7.2.1.
Japan
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.2.1.1.
On body
15.7.2.1.2.
Off body
15.7.2.2.
Japan
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.2.2.1.
Mechanical
15.7.2.2.2.
Electronic
15.7.2.3.
Japan
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
15.7.2.3.1.
Spring
based
15.7.2.3.2.
Motor
driven
15.7.2.3.3.
Rotary
Pump
15.7.2.3.4.
Pressurized
gas
15.7.2.3.5.
Expanding
battery
15.7.2.3.6.
Others
15.7.2.4.
Japan
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
15.7.2.4.1.
Diabetes
15.7.2.4.2.
Cardiovascular
disorders
15.7.2.4.3.
Oncology
15.7.2.4.4.
Infectious
Disease
15.7.2.4.5.
Autoimmune
Disease
15.7.2.4.6.
Others
15.7.2.5.
Japan
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
15.7.2.5.1.
Hospitals
and clinics
15.7.2.5.2.
Home
care centers
15.7.2.5.3.
Ambulatory
Centers
15.7.2.5.4.
Others
15.7.3. India
15.7.3.1.
India
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.3.1.1.
On body
15.7.3.1.2.
Off body
15.7.3.2.
India
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.3.2.1.
Mechanical
15.7.3.2.2.
Electronic
15.7.3.3.
India
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
15.7.3.3.1.
Spring
based
15.7.3.3.2.
Motor
driven
15.7.3.3.3.
Rotary
Pump
15.7.3.3.4.
Pressurized
gas
15.7.3.3.5.
Expanding
battery
15.7.3.3.6.
Others
15.7.3.4.
India
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
15.7.3.4.1.
Diabetes
15.7.3.4.2.
Cardiovascular
disorders
15.7.3.4.3.
Oncology
15.7.3.4.4.
Infectious
Disease
15.7.3.4.5.
Autoimmune
Disease
15.7.3.4.6.
Others
15.7.3.5.
India
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
15.7.3.5.1.
Hospitals
and clinics
15.7.3.5.2.
Home
care centers
15.7.3.5.3.
Ambulatory
Centers
15.7.3.5.4.
Others
15.7.4. New Zealand
15.7.4.1.
New Zealand
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.4.1.1.
On body
15.7.4.1.2.
Off body
15.7.4.2.
New
Zealand Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.4.2.1.
Mechanical
15.7.4.2.2.
Electronic
15.7.4.3.
New
Zealand Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
15.7.4.3.1.
Spring
based
15.7.4.3.2.
Motor
driven
15.7.4.3.3.
Rotary
Pump
15.7.4.3.4.
Pressurized
gas
15.7.4.3.5.
Expanding
battery
15.7.4.3.6.
Others
15.7.4.4.
New
Zealand Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.4.4.1.
Diabetes
15.7.4.4.2.
Cardiovascular
disorders
15.7.4.4.3.
Oncology
15.7.4.4.4.
Infectious
Disease
15.7.4.4.5.
Autoimmune
Disease
15.7.4.4.6.
Others
15.7.4.5.
New
Zealand Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
15.7.4.5.1.
Hospitals
and clinics
15.7.4.5.2.
Home
care centers
15.7.4.5.3.
Ambulatory
Centers
15.7.4.5.4.
Others
15.7.5. Australia
15.7.5.1.
Australia
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.5.1.1.
On body
15.7.5.1.2.
Off body
15.7.5.2.
Australia
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.5.2.1.
Mechanical
15.7.5.2.2.
Electronic
15.7.5.3.
Australia
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
15.7.5.3.1.
Spring
based
15.7.5.3.2.
Motor
driven
15.7.5.3.3.
Rotary
Pump
15.7.5.3.4.
Pressurized
gas
15.7.5.3.5.
Expanding
battery
15.7.5.3.6.
Others
15.7.5.4.
Australia
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
15.7.5.4.1.
Diabetes
15.7.5.4.2.
Cardiovascular
disorders
15.7.5.4.3.
Oncology
15.7.5.4.4.
Infectious
Disease
15.7.5.4.5.
Autoimmune
Disease
15.7.5.4.6.
Others
15.7.5.5.
Australia
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
15.7.5.5.1.
Hospitals
and clinics
15.7.5.5.2.
Home
care centers
15.7.5.5.3.
Ambulatory
Centers
15.7.5.5.4.
Others
15.7.6. South Korea
15.7.6.1.
South
Korea Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.6.1.1.
On body
15.7.6.1.2.
Off body
15.7.6.2.
South
Korea Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.6.2.1.
Mechanical
15.7.6.2.2.
Electronic
15.7.6.3.
South
Korea Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
15.7.6.3.1.
Spring
based
15.7.6.3.2.
Motor
driven
15.7.6.3.3.
Rotary
Pump
15.7.6.3.4.
Pressurized
gas
15.7.6.3.5.
Expanding
battery
15.7.6.3.6.
Others
15.7.6.4.
South
Korea Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
15.7.6.4.1.
Diabetes
15.7.6.4.2.
Cardiovascular
disorders
15.7.6.4.3.
Oncology
15.7.6.4.4.
Infectious
Disease
15.7.6.4.5.
Autoimmune
Disease
15.7.6.4.6.
Others
15.7.6.5.
South Korea
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
15.7.6.5.1.
Hospitals
and clinics
15.7.6.5.2.
Home
care centers
15.7.6.5.3.
Ambulatory
Centers
15.7.6.5.4.
Others
15.7.7. Southeast Asia
15.7.7.1.
Southeast
Asia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.7.1.1.
On body
15.7.7.1.2.
Off body
15.7.7.2.
Southeast
Asia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
15.7.7.2.1.
Mechanical
15.7.7.2.2.
Electronic
15.7.7.3.
Southeast
Asia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
15.7.7.3.1.
Spring
based
15.7.7.3.2.
Motor
driven
15.7.7.3.3.
Rotary
Pump
15.7.7.3.4.
Pressurized
gas
15.7.7.3.5.
Expanding
battery
15.7.7.3.6.
Others
15.7.7.4.
Southeast
Asia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
15.7.7.4.1.
Diabetes
15.7.7.4.2.
Cardiovascular
disorders
15.7.7.4.3.
Oncology
15.7.7.4.4.
Infectious
Disease
15.7.7.4.5.
Autoimmune
Disease
15.7.7.4.6.
Others
15.7.7.5.
Southeast
Asia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
15.7.7.5.1.
Hospitals
and clinics
15.7.7.5.2.
Home
care centers
15.7.7.5.3.
Ambulatory
Centers
15.7.7.5.4.
Others
15.7.7.6.
Southeast
Asia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Country
15.7.7.6.1.
Indonesia
15.7.7.6.2.
Thailand
15.7.7.6.3.
Malaysia
15.7.7.6.4.
Singapore
15.7.7.6.5.
Rest of
Southeast Asia
15.7.8. Rest of Asia Pacific
15.7.8.1.
Rest of
Asia Pacific Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
15.7.8.1.1.
On body
15.7.8.1.2.
Off body
15.7.8.2.
Rest of
Asia Pacific Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Technology
15.7.8.2.1.
Mechanical
15.7.8.2.2.
Electronic
15.7.8.3.
Rest of
Asia Pacific Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Mechanism
15.7.8.3.1.
Spring
based
15.7.8.3.2.
Motor
driven
15.7.8.3.3.
Rotary
Pump
15.7.8.3.4.
Pressurized
gas
15.7.8.3.5.
Expanding
battery
15.7.8.3.6.
Others
15.7.8.4.
Rest of
Asia Pacific Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Application
15.7.8.4.1.
Diabetes
15.7.8.4.2.
Cardiovascular
disorders
15.7.8.4.3.
Oncology
15.7.8.4.4.
Infectious
Disease
15.7.8.4.5.
Autoimmune
Disease
15.7.8.4.6.
Others
15.7.8.5.
Rest of
Asia Pacific Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End
User
15.7.8.5.1.
Hospitals
and clinics
15.7.8.5.2.
Home
care centers
15.7.8.5.3.
Ambulatory
Centers
15.7.8.5.4.
Others
15.8. Key Segment for Channeling Investments
15.8.1. By Country
15.8.2. By Type
15.8.3. By Technology
15.8.4. By Mechanism
15.8.5. By Application
15.8.6. By End User
16. Middle East and Africa Wearable Injectors
Market Analysis and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Middle East and Africa Wearable Injectors
Market Revenue (US$ Mn)
16.2. Middle East and Africa Wearable Injectors
Market Revenue (US$ Mn) and Forecasts, By Type
16.2.1. On body
16.2.2. Off body
16.3. Middle East and Africa Wearable Injectors
Market Revenue (US$ Mn) and Forecasts, By Technology
16.3.1. Mechanical
16.3.2. Electronic
16.4. Middle East and Africa Wearable Injectors
Market Revenue (US$ Mn) and Forecasts, By Mechanism
16.4.1. Spring based
16.4.2. Motor driven
16.4.3. Rotary Pump
16.4.4. Pressurized gas
16.4.5. Expanding battery
16.4.6. Others
16.5. Middle East and Africa Wearable Injectors
Market Revenue (US$ Mn) and Forecasts, By Application
16.5.1. Diabetes
16.5.2. Cardiovascular disorders
16.5.3. Oncology
16.5.4. Infectious Disease
16.5.5. Autoimmune Disease
16.5.6. Others
16.6. Middle East and Africa Wearable Injectors
Market Revenue (US$ Mn) and Forecasts, By End User
16.6.1. Hospitals and clinics
16.6.2. Home care centers
16.6.3. Ambulatory Centers
16.6.4. Others
16.7. Middle East and Africa Wearable Injectors
Market Revenue (US$ Mn) and Forecasts, By Country
16.7.1. Saudi Arabia
16.7.1.1.
Saudi
Arabia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
16.7.1.1.1.
On body
16.7.1.1.2.
Off body
16.7.1.2.
Saudi
Arabia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.1.2.1.
Mechanical
16.7.1.2.2.
Electronic
16.7.1.3.
Saudi
Arabia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
16.7.1.3.1.
Spring
based
16.7.1.3.2.
Motor
driven
16.7.1.3.3.
Rotary
Pump
16.7.1.3.4.
Pressurized
gas
16.7.1.3.5.
Expanding
battery
16.7.1.3.6.
Others
16.7.1.4.
Saudi
Arabia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
16.7.1.4.1.
Diabetes
16.7.1.4.2.
Cardiovascular
disorders
16.7.1.4.3.
Oncology
16.7.1.4.4.
Infectious
Disease
16.7.1.4.5.
Autoimmune
Disease
16.7.1.4.6.
Others
16.7.1.5.
Saudi
Arabia Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
16.7.1.5.1.
Hospitals
and clinics
16.7.1.5.2.
Home
care centers
16.7.1.5.3.
Ambulatory
Centers
16.7.1.5.4.
Others
16.7.2. UAE
16.7.2.1.
UAE
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
16.7.2.1.1.
On body
16.7.2.1.2.
Off body
16.7.2.2.
UAE
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.2.2.1.
Mechanical
16.7.2.2.2.
Electronic
16.7.2.3.
UAE
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
16.7.2.3.1.
Spring
based
16.7.2.3.2.
Motor
driven
16.7.2.3.3.
Rotary
Pump
16.7.2.3.4.
Pressurized
gas
16.7.2.3.5.
Expanding
battery
16.7.2.3.6.
Others
16.7.2.4.
UAE
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
16.7.2.4.1.
Diabetes
16.7.2.4.2.
Cardiovascular
disorders
16.7.2.4.3.
Oncology
16.7.2.4.4.
Infectious
Disease
16.7.2.4.5.
Autoimmune
Disease
16.7.2.4.6.
Others
16.7.2.5.
UAE
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
16.7.2.5.1.
Hospitals
and clinics
16.7.2.5.2.
Home
care centers
16.7.2.5.3.
Ambulatory
Centers
16.7.2.5.4.
Others
16.7.3. Egypt
16.7.3.1.
Egypt
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
16.7.3.1.1.
On body
16.7.3.1.2.
Off body
16.7.3.2.
Egypt
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.3.2.1.
Mechanical
16.7.3.2.2.
Electronic
16.7.3.3.
Egypt
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
16.7.3.3.1.
Spring
based
16.7.3.3.2.
Motor
driven
16.7.3.3.3.
Rotary
Pump
16.7.3.3.4.
Pressurized
gas
16.7.3.3.5.
Expanding
battery
16.7.3.3.6.
Others
16.7.3.4.
Egypt
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
16.7.3.4.1.
Diabetes
16.7.3.4.2.
Cardiovascular
disorders
16.7.3.4.3.
Oncology
16.7.3.4.4.
Infectious
Disease
16.7.3.4.5.
Autoimmune
Disease
16.7.3.4.6.
Others
16.7.3.5.
Egypt
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
16.7.3.5.1.
Hospitals
and clinics
16.7.3.5.2.
Home
care centers
16.7.3.5.3.
Ambulatory
Centers
16.7.3.5.4.
Others
16.7.4. Kuwait
16.7.4.1.
Kuwait
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
16.7.4.1.1.
On body
16.7.4.1.2.
Off body
16.7.4.2.
Kuwait
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.4.2.1.
Mechanical
16.7.4.2.2.
Electronic
16.7.4.3.
Kuwait
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
16.7.4.3.1.
Spring
based
16.7.4.3.2.
Motor
driven
16.7.4.3.3.
Rotary
Pump
16.7.4.3.4.
Pressurized
gas
16.7.4.3.5.
Expanding
battery
16.7.4.3.6.
Others
16.7.4.4.
Kuwait
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
16.7.4.4.1.
Diabetes
16.7.4.4.2.
Cardiovascular
disorders
16.7.4.4.3.
Oncology
16.7.4.4.4.
Infectious
Disease
16.7.4.4.5.
Autoimmune
Disease
16.7.4.4.6.
Others
16.7.4.5.
Kuwait
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
16.7.4.5.1.
Hospitals
and clinics
16.7.4.5.2.
Home
care centers
16.7.4.5.3.
Ambulatory
Centers
16.7.4.5.4.
Others
16.7.5. South Africa
16.7.5.1.
South
Africa Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
16.7.5.1.1.
On body
16.7.5.1.2.
Off body
16.7.5.2.
South
Africa Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
16.7.5.2.1.
Mechanical
16.7.5.2.2.
Electronic
16.7.5.3.
South
Africa Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
16.7.5.3.1.
Spring
based
16.7.5.3.2.
Motor
driven
16.7.5.3.3.
Rotary
Pump
16.7.5.3.4.
Pressurized
gas
16.7.5.3.5.
Expanding
battery
16.7.5.3.6.
Others
16.7.5.4.
South
Africa Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
16.7.5.4.1.
Diabetes
16.7.5.4.2.
Cardiovascular
disorders
16.7.5.4.3.
Oncology
16.7.5.4.4.
Infectious
Disease
16.7.5.4.5.
Autoimmune
Disease
16.7.5.4.6.
Others
16.7.5.5.
South
Africa Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
16.7.5.5.1.
Hospitals
and clinics
16.7.5.5.2.
Home
care centers
16.7.5.5.3.
Ambulatory
Centers
16.7.5.5.4.
Others
16.7.6. Rest of Middle East & Africa
16.7.6.1.
Rest of
Middle East & Africa Wearable Injectors Market Revenue (US$ Mn) and
Forecasts, By Type
16.7.6.1.1.
On body
16.7.6.1.2.
Off body
16.7.6.2.
Rest of
Middle East & Africa Wearable Injectors Market Revenue (US$ Mn) and
Forecasts, By Technology
16.7.6.2.1.
Mechanical
16.7.6.2.2.
Electronic
16.7.6.3.
Rest of
Middle East & Africa Wearable Injectors Market Revenue (US$ Mn) and
Forecasts, By Mechanism
16.7.6.3.1.
Spring
based
16.7.6.3.2.
Motor
driven
16.7.6.3.3.
Rotary
Pump
16.7.6.3.4.
Pressurized
gas
16.7.6.3.5.
Expanding
battery
16.7.6.3.6.
Others
16.7.6.4.
Rest of
Middle East & Africa Wearable Injectors Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.6.4.1.
Diabetes
16.7.6.4.2.
Cardiovascular
disorders
16.7.6.4.3.
Oncology
16.7.6.4.4.
Infectious
Disease
16.7.6.4.5.
Autoimmune
Disease
16.7.6.4.6.
Others
16.7.6.5.
Rest of
Middle East & Africa Wearable Injectors Market Revenue (US$ Mn) and
Forecasts, By End User
16.7.6.5.1.
Hospitals
and clinics
16.7.6.5.2.
Home
care centers
16.7.6.5.3.
Ambulatory
Centers
16.7.6.5.4.
Others
16.8. Key Segment for Channeling Investments
16.8.1. By Country
16.8.2. By Type
16.8.3. By Technology
16.8.4. By Mechanism
16.8.5. By Application
16.8.6. By End User
17. Latin America Wearable Injectors Market
Analysis and Forecasts, 2022 – 2030
17.1. Overview
17.1.1. Latin America Wearable Injectors Market
Revenue (US$ Mn)
17.2. Latin America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Type
17.2.1. On body
17.2.2. Off body
17.3. Latin America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Technology
17.3.1. Mechanical
17.3.2. Electronic
17.4. Latin America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Mechanism
17.4.1. Spring based
17.4.2. Motor driven
17.4.3. Rotary Pump
17.4.4. Pressurized gas
17.4.5. Expanding battery
17.4.6. Others
17.5. Latin America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Application
17.5.1. Diabetes
17.5.2. Cardiovascular disorders
17.5.3. Oncology
17.5.4. Infectious Disease
17.5.5. Autoimmune Disease
17.5.6. Others
17.6. Latin America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By End User
17.6.1. Hospitals and clinics
17.6.2. Home care centers
17.6.3. Ambulatory Centers
17.6.4. Others
17.7. Latin America Wearable Injectors Market
Revenue (US$ Mn) and Forecasts, By Country
17.7.1. Brazil
17.7.1.1.
Brazil
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
17.7.1.1.1.
On body
17.7.1.1.2.
Off body
17.7.1.2.
Brazil
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
17.7.1.2.1.
Mechanical
17.7.1.2.2.
Electronic
17.7.1.3.
Brazil
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
17.7.1.3.1.
Spring
based
17.7.1.3.2.
Motor
driven
17.7.1.3.3.
Rotary
Pump
17.7.1.3.4.
Pressurized
gas
17.7.1.3.5.
Expanding
battery
17.7.1.3.6.
Others
17.7.1.4.
Brazil
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
17.7.1.4.1.
Diabetes
17.7.1.4.2.
Cardiovascular
disorders
17.7.1.4.3.
Oncology
17.7.1.4.4.
Infectious
Disease
17.7.1.4.5.
Autoimmune
Disease
17.7.1.4.6.
Others
17.7.1.5.
Brazil
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
17.7.1.5.1.
Hospitals
and clinics
17.7.1.5.2.
Home
care centers
17.7.1.5.3.
Ambulatory
Centers
17.7.1.5.4.
Others
17.7.2. Argentina
17.7.2.1.
Argentina
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
17.7.2.1.1.
On body
17.7.2.1.2.
Off body
17.7.2.2.
Argentina
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Technology
17.7.2.2.1.
Mechanical
17.7.2.2.2.
Electronic
17.7.2.3.
Argentina
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Mechanism
17.7.2.3.1.
Spring
based
17.7.2.3.2.
Motor
driven
17.7.2.3.3.
Rotary
Pump
17.7.2.3.4.
Pressurized
gas
17.7.2.3.5.
Expanding
battery
17.7.2.3.6.
Others
17.7.2.4.
Argentina
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Application
17.7.2.4.1.
Diabetes
17.7.2.4.2.
Cardiovascular
disorders
17.7.2.4.3.
Oncology
17.7.2.4.4.
Infectious
Disease
17.7.2.4.5.
Autoimmune
Disease
17.7.2.4.6.
Others
17.7.2.5.
Argentina
Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End User
17.7.2.5.1.
Hospitals
and clinics
17.7.2.5.2.
Home
care centers
17.7.2.5.3.
Ambulatory
Centers
17.7.2.5.4.
Others
17.7.3. Rest of Latin America
17.7.3.1.
Rest of
Latin America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By Type
17.7.3.1.1.
On body
17.7.3.1.2.
Off body
17.7.3.2.
Rest of
Latin America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Technology
17.7.3.2.1.
Mechanical
17.7.3.2.2.
Electronic
17.7.3.3.
Rest of
Latin America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Mechanism
17.7.3.3.1.
Spring
based
17.7.3.3.2.
Motor
driven
17.7.3.3.3.
Rotary
Pump
17.7.3.3.4.
Pressurized
gas
17.7.3.3.5.
Expanding
battery
17.7.3.3.6.
Others
17.7.3.4.
Rest of
Latin America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By
Application
17.7.3.4.1.
Diabetes
17.7.3.4.2.
Cardiovascular
disorders
17.7.3.4.3.
Oncology
17.7.3.4.4.
Infectious
Disease
17.7.3.4.5.
Autoimmune
Disease
17.7.3.4.6.
Others
17.7.3.5.
Rest of
Latin America Wearable Injectors Market Revenue (US$ Mn) and Forecasts, By End
User
17.7.3.5.1.
Hospitals
and clinics
17.7.3.5.2.
Home
care centers
17.7.3.5.3.
Ambulatory
Centers
17.7.3.5.4.
Others
17.8. Key Segment for Channeling Investments
17.8.1. By Country
17.8.2. By Type
17.8.3. By Technology
17.8.4. By Mechanism
17.8.5. By Application
17.8.6. By End User
18. Competitive Benchmarking
18.1. Brand Benchmarking
18.2. Market Share Analysis, 2021
18.3. Global Presence and Growth Strategies
18.3.1. Mergers and Acquisitions
18.3.2. Product Launches
18.3.3. Investments Trends
18.3.4. R&D Initiatives
19. Player Profiles
19.1. Amgen
19.1.1. Company Details
19.1.2. Company Overview
19.1.3. Product Offerings
19.1.4. Key Developments
19.1.5. Financial Analysis
19.1.6. SWOT Analysis
19.1.7. Business Strategies
19.2. BD
19.2.1. Company Details
19.2.2. Company Overview
19.2.3. Product Offerings
19.2.4. Key Developments
19.2.5. Financial Analysis
19.2.6. SWOT Analysis
19.2.7. Business Strategies
19.3. Bühler Motor GmbH
19.3.1. Company Details
19.3.2. Company Overview
19.3.3. Product Offerings
19.3.4. Key Developments
19.3.5. Financial Analysis
19.3.6. SWOT Analysis
19.3.7. Business Strategies
19.4. EOFLOW CO., LTD.
19.4.1. Company Details
19.4.2. Company Overview
19.4.3. Product Offerings
19.4.4. Key Developments
19.4.5. Financial Analysis
19.4.6. SWOT Analysis
19.4.7. Business Strategies
19.5. Gerresheimer AG
19.5.1. Company Details
19.5.2. Company Overview
19.5.3. Product Offerings
19.5.4. Key Developments
19.5.5. Financial Analysis
19.5.6. SWOT Analysis
19.5.7. Business Strategies
19.6. Insulet Corporation
19.6.1. Company Details
19.6.2. Company Overview
19.6.3. Product Offerings
19.6.4. Key Developments
19.6.5. Financial Analysis
19.6.6. SWOT Analysis
19.6.7. Business Strategies
19.7. Neuma LLC
19.7.1. Company Details
19.7.2. Company Overview
19.7.3. Product Offerings
19.7.4. Key Developments
19.7.5. Financial Analysis
19.7.6. SWOT Analysis
19.7.7. Business Strategies
19.8. Sonceboz
19.8.1. Company Details
19.8.2. Company Overview
19.8.3. Product Offerings
19.8.4. Key Developments
19.8.5. Financial Analysis
19.8.6. SWOT Analysis
19.8.7. Business Strategies
19.9. United Therapeutics
19.9.1. Company Details
19.9.2. Company Overview
19.9.3. Product Offerings
19.9.4. Key Developments
19.9.5. Financial Analysis
19.9.6. SWOT Analysis
19.9.7. Business Strategies
19.10. West Pharmaceutical Services
19.10.1. Company Details
19.10.2. Company Overview
19.10.3. Product Offerings
19.10.4. Key Developments
19.10.5. Financial Analysis
19.10.6. SWOT Analysis
19.10.7. Business Strategies
19.11. Ypsomed AG
19.11.1. Company Details
19.11.2. Company Overview
19.11.3. Product Offerings
19.11.4. Key Developments
19.11.5. Financial Analysis
19.11.6. SWOT Analysis
19.11.7. Business Strategies
19.12. Other Market Participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.